Fybrix’s synthetic gel mimics biological cell environments, offering animal-free production and easy tunability. Its unique features enable stem cell culture, tumour organoid formation, drug screening, wound healing stimulation, and controlled drug release. Fybrix is easy-to-use, reproducible, and cost-effective, making it an ideal solution for biomedical applications.

Founders:
Lotte Gerrits

Paul Kouwer

Focus area:
Academia and Pharmaceutical industry

Complies with the following Sustainable Development Goals:
SDG 3: Good health and wellbeing

Contact information:
LinkedIn